Published in Arthritis Rheum on June 01, 1983
Pathogenesis of systemic lupus erythematosus. J Clin Pathol (2003) 2.93
Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest (1985) 1.18
High incidence of herpes zoster in patients with systemic lupus erythematosus: an immunological analysis. Ann Rheum Dis (1990) 1.00
Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity. Mediators Inflamm (2001) 0.98
Studies on human blood lymphocytes with iC3b (type 3) complement receptors. II. Characterization of subsets which regulate pokeweed mitogen-induced lymphocyte proliferation and immunoglobulin synthesis. Clin Exp Immunol (1987) 0.86
Characterization of lymphocytes that suppress IL-2 production in systemic lupus erythematosus. Clin Exp Immunol (1988) 0.84
Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus. Clin Rheumatol (2009) 0.79
Studies on human blood lymphocytes with iC3b (type 3) complement receptors: III. Abnormalities in patients with active systemic lupus erythematosus. Clin Exp Immunol (1987) 0.78
The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus. Arthritis Res Ther (2006) 0.76
Evidence against HLA and immunological dependence of disease outbreak in SLE. Immunological characterisation of identical twins clinically discordant for SLE. Ann Rheum Dis (1985) 0.75
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med (1999) 6.84
Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med (1995) 3.93
Identification of two populations of immunoglobulin-bearing lymphocytes in man. J Immunol (1975) 3.83
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol (2001) 3.63
Identification of human mononuclear leucocyte populations by esterase staining. Clin Exp Immunol (1977) 3.12
Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol (1983) 2.95
Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin. J Clin Invest (1975) 2.78
The choroid plexus in systemic lupus erythematosus. Ann Intern Med (1972) 2.69
Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest (1997) 2.57
Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med (1972) 2.20
An appraisal of Fc receptors on human peripheral blood B and L lymphocytes. J Immunol (1976) 2.05
Synovitis of recent onset. A clinicopathologic study during the first month of disease. Arthritis Rheum (1973) 2.03
Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum (1972) 1.88
1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol (1985) 1.79
Evidence by reactivity with hybridoma antibodies for a probable myeloid origin of peripheral blood cells active in natural cytotoxicity and antibody-dependent cell-mediated cytotoxicity. J Clin Invest (1980) 1.78
Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med (1989) 1.75
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest (1972) 1.60
Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum. Diabetes Care (1995) 1.59
Distinctive functional properties of human blood L lymphocytes: a comparison with T lymphocytes, B lymphocytes, and monocytes. J Immunol (1977) 1.57
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55
Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet (1999) 1.50
A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med (1975) 1.50
The relationship between defects in lymphocyte production of transforming growth factor-beta1 in systemic lupus erythematosus and disease activity or severity. Lupus (1999) 1.45
Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus. Clin Exp Immunol (1975) 1.44
Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41
Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol (1977) 1.39
Impairments of the protein C system and fibrinolysis in infection-associated stroke. Stroke (1996) 1.38
The elusive search for geographic clusters of systemic lupus erythematosus. Critical review. Arthritis Rheum (1995) 1.38
Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol (1977) 1.36
Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum (1983) 1.35
Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med (2006) 1.32
Spontaneous and induced cytotoxic properties of human adherent mononuclear cells: killing of non-sensitized and antibody-coated non-erythroid cells. Immunology (1979) 1.24
Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum (1998) 1.24
Regional differences in myocyte size in normal rat heart. Anat Rec (1986) 1.21
Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med (1970) 1.20
Identification of the genes responsive to etoposide-induced apoptosis: application of DNA chip technology. FEBS Lett (1999) 1.20
Antiviral antibodies in rheumatoid synovial fluid and cryoprecipitates. Clin Exp Immunol (1974) 1.20
Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus. J Immunol (1998) 1.20
CD8+ lymphocytes from patients with systemic lupus erythematosus sustain, rather than suppress, spontaneous polyclonal IgG production and synergize with CD4+ cells to support autoantibody synthesis. Arthritis Rheum (1990) 1.19
Age-related differences in breast cancer treatment. Ann Surg Oncol (1994) 1.18
Correction of interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest (1985) 1.18
Pulmonary involvement in adult-onset Still's disease. Curr Opin Pulm Med (1999) 1.17
Plant thorn synovitis. Arthritis Rheum (1977) 1.17
DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood (1998) 1.16
Methyldopa inhibition of suppressor-lymphocyte function: a proposed cause of autoimmune hemolytic anemia. N Engl J Med (1980) 1.15
Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation or by injection with T-enriched splenocytes. Clin Exp Immunol (2003) 1.12
Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum (1984) 1.12
Pseudomonas botryomycosis. Arch Dermatol (1976) 1.11
Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin 2. Eur J Immunol (1985) 1.11
Septic arthritis in systemic lupus erythematosus. J Rheumatol (1975) 1.10
Surface markers and electron microscopy of human blood L cells: a comparison with T and B lymphocytes. J Immunol (1978) 1.08
Identification of new SLE-associated genes with a two-step Bayesian study design. Genes Immun (2009) 1.07
Esophageal dysfunction in patients with mixed connective tissue diseases and systemic lupus erythematosus. Dig Dis Sci (1982) 1.07
Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). Arthritis Rheum (1974) 1.07
Anticardiolipin antibodies in unselected autoimmune rheumatic disease patients. Clin Immunol Immunopathol (1987) 1.07
Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radic Biol Med (1993) 1.06
Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol (1992) 1.04
Immunological studies in familial primary biliary cirrhosis. Gastroenterology (1976) 1.04
Further characterization of low density mononuclear cells: FACS-assisted analysis of human MLR stimulators. J Immunol (1985) 1.02
IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis. Clin Exp Immunol (1983) 1.02
Purification and properties of Paracoccus denitrificans Azurin. Arch Biochem Biophys (1980) 1.02
Conditions required for Fc-dependent immune complex enhancement of antigen-specific lymphocyte blastogenesis. J Immunol (1980) 1.02
Ductular carcinoma of the breast: serum antibodies to tumor-associated antigens. Cancer (1979) 1.02
The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells. J Exp Med (1994) 1.01
Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin. J Immunol (1984) 1.00
Herpes gestationis in association with a hydatidiform mole. Immunopathologic studies. Arch Dermatol (1981) 1.00
Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells. Clin Exp Immunol (1977) 1.00
T-cell receptor variable beta genes show differential expression in CD4 and CD8 T cells. Hum Immunol (1991) 0.99
Cardiac compression in rheumatoid pericarditis. Semin Arthritis Rheum (1990) 0.98
Immunologic responses in patients with lepromatous leprosy. Arch Dermatol (1976) 0.98
Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. J Immunol (1982) 0.98
Histochemical studies for 5'-nucleotidase and alpha-naphthyl (non-specific) esterase in lymphocytes from patients with primary immunoglobulin deficiencies. Clin Exp Immunol (1979) 0.98
Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections. Ann Rheum Dis (2002) 0.98
Activated human NK cells can stimulate resting B cells to secrete immunoglobulin. J Immunol (1995) 0.97
Effect of dexamethasone on hexamethylene bisacetamide-induced Friend cell erythrodifferentiation. Cancer Res (1982) 0.96
Generation of an inhibitory circuit involving CD8+ T cells, IL-2, and NK cell-derived TGF-beta: contrasting effects of anti-CD2 and anti-CD3. J Immunol (1998) 0.96
Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method. J Rheumatol (1980) 0.95
Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. Arch Dermatol (1985) 0.95
Breast reconstruction in older women. Surgery (1994) 0.95
Lupus foot: deforming arthropathy of the feet in systemic lupus erythematosus. J Rheumatol (1984) 0.94
Cryoglobulinaemia in patients with infectious endocarditis. Clin Exp Immunol (1975) 0.94
Pulmonary involvement in primary biliary cirrhosis. J Clin Gastroenterol (1987) 0.94
IgG antibodies to double-stranded DNA in systemic lupus erythematosus sera. Independent variation of complement fixing activity and total antibody content. Arthritis Rheum (1979) 0.93